Softwr

Healthcare · head to head

Lunit vs Omada Health

Lunit logo

Lunit

Healthcare

FDA cleared and CE marked AI for mammography, tomosynthesis and chest radiography

From
On request
Rated
-
Full reviewWebsite
Omada Health logo

Omada Health

Healthcare

Behavioral health management platform

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Lunit the regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.; Omada Health no direct-pay pricing disclosed; programs only available through employer or health plan coverage
  • They diverge on capability: Lunit covers Lunit INSIGHT MMG, Omada Health covers Chronic Disease Management.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Lunit and Omada Health actually diverge.

Attributes where Lunit and Omada Health differ
AttributeLunitOmada Health
PlatformsWebWeb, Mobile
FoundedUnknown2011

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Lunit

  • Lunit INSIGHT MMG
  • Lunit INSIGHT DBT
  • Lunit INSIGHT CXR
  • Volpara density assessment
  • Volpara RiskPathways
  • Volpara dose tracking
  • PACS and mammography workstation integration

Only in Omada Health

  • Chronic Disease Management
  • Behavioral Health
  • Coaching
  • Mobile App
  • Analytics
  • Incentives
  • Health Plans
  • EHR Systems

What people use each for

The jobs each tool is most often brought in to do.

Lunit

  • A national breast screening programme evaluating AI as a second reader to reduce double reading workload where two human readers are currently mandatednot Omada Health
  • A breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on DBT specificallynot Omada Health
  • An American breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what Volpara is bought fornot Omada Health
  • A tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise filmsnot Omada Health

Omada Health

  • Employer-sponsored diabetes prevention and weight health programmesnot Lunit
  • Remote monitoring of hypertension and diabetes with connected devicesnot Lunit
  • GLP-1 support programmes alongside medicationnot Lunit
  • Musculoskeletal care delivered virtuallynot Lunit

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Lunit

  • The regulatory permission differs by product and by region, and INSIGHT Risk has been filed with the FDA but not cleared, so a buyer who reads a corporate press release rather than the specific clearance for their product and jurisdiction will plan a deployment they cannot legally run.
  • Detection AI changes recall rates in screening, and the downstream cost of additional diagnostic workup lands on the programme rather than on the software budget, which is the cost most screening business cases omit.
  • Performance is sensitive to the mammography vendor and acquisition protocol, so published results from a Hologic estate do not transfer to a GE or Siemens estate without local validation the buyer must fund.
  • MMG, DBT and CXR are licensed separately and Volpara modules are separate again, so a breast centre wanting detection, density and risk pathways is assembling four line items rather than buying one product.
  • Using AI as a replacement for one of two human readers is a workforce and liability decision that regulators and professional bodies treat differently in each country, so the saving that justifies the purchase may not be permitted where you operate.

Omada Health

  • No direct-pay pricing disclosed; programs only available through employer or health plan coverage
  • Eligibility varies by employer and health plan
  • Government payer programs (Medicare/Medicaid) have different device access rules
  • MSK program may require out-of-pocket costs depending on individual health plans

Pricing, plan by plan

Lunit

On request
  • Lunit INSIGHT$undefined/year
    • Priced per study or per annual examination volume by product
    • MMG, DBT and CXR licensed separately
    • Volpara density and RiskPathways modules quoted separately

Omada Health

On request

No published plan breakdown. See the Omada Health review.

Which should you pick?

Choose Lunit if

  • You need lunit insight mmg.
  • You also want lunit insight dbt.
Lunit review

Choose Omada Health if

  • You need chronic disease management.
  • You work on Web, Mobile.
  • You also want behavioral health.
Omada Health review

Questions people ask

Is Lunit or Omada Health better?
Neither clearly leads. Lunit starts at On request and Omada Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Lunit or Omada Health?
Lunit starts at On request and Omada Health at On request.
Does Lunit or Omada Health run on more platforms?
Lunit runs on Web. Omada Health runs on Web, Mobile.
What is Lunit best used for?
Lunit is most often used for a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated, a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically, an american breast imaging centre needing automated volumetric density assessment to meet patient density notification requirements, which is what volpara is bought for, a tuberculosis or lung screening programme in a high volume, radiologist scarce setting using chest radiography triage to prioritise films. Of those, a national breast screening programme evaluating ai as a second reader to reduce double reading workload where two human readers are currently mandated and a breast centre that moved to tomosynthesis and now has reading times it cannot staff, wanting detection support on dbt specifically are not what Omada Health is typically brought in for.
What can Lunit do that Omada Health cannot?
Lunit covers Lunit INSIGHT MMG, Lunit INSIGHT DBT, Lunit INSIGHT CXR, Volpara density assessment. Omada Health covers Chronic Disease Management, Behavioral Health, Coaching, Mobile App.

Answered from the vendors’ own pages

Lunit: Is Lunit FDA cleared?

Yes for specific products. INSIGHT MMG, INSIGHT DBT and INSIGHT CXR Triage hold FDA 510(k) clearances. INSIGHT Risk, the five year risk prediction model, has been filed but was not cleared at the time of writing.

Omada Health: How much does Omada Health cost?

Omada Health programs are offered at no cost to members when covered by an employer or health plan. Direct-pay pricing for uninsured individuals is not disclosed on the website.

Source
Lunit: Can Lunit replace a second human reader in screening?

That depends entirely on your jurisdiction and professional body guidance, not on the software. The CE mark permits clinical use; it does not authorise a workforce model.

Omada Health: Is Omada Health free?

Omada's Prevention, Diabetes, and Hypertension programs are free when covered by your employer or health plan. The Joint and Muscle Health program is subject to deductibles, copays, and co-insurance as determined under your health plan.

Source
Lunit: What did the Volpara acquisition add?

Volumetric breast density measurement, dose tracking and RiskPathways high risk programme management, which are the things American breast centres buy for density notification compliance rather than for detection.

Omada Health: Do I need to pay for the Omada welcome kit with smart devices?

The welcome kit containing smart devices is offered at no cost to covered members. Continuous glucose monitors for diabetes program participants are also provided at no additional charge, though Medicare and Medicaid are excluded.

Source
Lunit: Is pricing published?

No. It is quoted per study or per annual volume, by product, with on premises and cloud priced differently.

Share

Related pages

More on Lunit

More on Omada Health

Keep looking

Other head to heads